Financial Summary for the Fiscal Year Ending December 2025 [IFRS] (Consolidated)

Performance Overview

For the fiscal year ending December 2025, consolidated results were net sales of ¥945,268 million (4.4% decrease YoY), core operating income of ¥108,884 million (21.4% decrease YoY), income before income taxes of ¥105,386 million (21.7% decrease YoY), and net income attributable to owners of parent of ¥65,212 million (20.3% decrease YoY). Overseas, delays in demand recovery in the Chinese market and intensified price competition compressed profitability in the Asia region. Meanwhile, domestic sales remained stable as daily necessities, and North America and the Middle East maintained steady sales growth. By segment, Personal Care recorded ¥774,428 million (6.3% decrease YoY), Pet Care ¥156,084 million (5.0% increase YoY), and Others ¥14,755 million (3.9% increase YoY).

Future Outlook and Dividend Policy

The fiscal year ending December 2026 is the first year of the 13th Medium-Term Management Plan, with forecasts of net sales of ¥1,010 billion (6.8% increase YoY), core operating income of ¥136,000 million (24.9% increase YoY), and net income attributable to owners of parent of ¥86,500 million (32.6% increase YoY). The Asian business recovery is positioned as a growth driver, with initiatives to revise pricing strategies and cost structures and strengthen digital marketing. The annual dividend is planned at ¥22 (22.2% increase YoY), targeting a total payout ratio of 65% and DOE of 4.5% or higher. Additionally, treasury stock acquisitions will be conducted flexibly.